School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Mark Rapaport MD

  • Department of Psychiatry and Behavioral Sciences
    Adjunct Professor
  • (404) 727-8382
  • mark.h.rapaport@emory.edu
Head shot of Mark Rapaport

Academic Appointment

  • Reunette W. Harris Professor and Chair, Psychiatry and Behavioral Sciences, Emory University, Atlanta

Education

Degrees

  • MD from University of California, San Diego, San Diego
  • BA from University of California, San Diego, San Diego

Research

Focus

  • I have had a number of research foci over the years, these include: human psychoneuroimmunology, psychopharmacology research, clinical trials methodology quality of life and complementary and alternative medicine.

Publications

  • Individuals with depression exhibiting a pro-inflammatory phenotype receiving omega-3 polyunsaturated fatty acids experience improved motivation-related cognitive function: Preliminary results from a randomized controlled trial.
    Brain Behav Immun Health Volume: 32 Page(s): 100666
    10/01/2023 Authors: Mac Giollabhui N; Mischoulon D; Dunlop BW; Kinkead B; Schettler PJ; Liu RT; Okereke OI; Lamon-Fava S; Fava M; Rapaport MH
  • Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators.
    Neuropsychopharmacology Volume: 48 Page(s): 929 - 935
    05/01/2023 Authors: Lamon-Fava S; Liu M; Dunlop BW; Kinkead B; Schettler PJ; Felger JC; Ziegler TR; Fava M; Mischoulon D; Rapaport MH
  • A Bipolar Learning Health Network: An innovation whose time has come.
    Bipolar Disord Volume: 25 Page(s): 177 - 180
    05/01/2023 Authors: Nierenberg AA; Margolis P; Strakowski S; Trivedi M; Yatham LN; Bipolar Disorder Learning Health Network
  • Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations.
    Nat Genet Volume: 55 Page(s): 369 - 376
    03/01/2023 Authors: Liu D; Meyer D; Fennessy B; Feng C; Cheng E; Johnson JS; Park YJ; Rieder M-K; Ascolillo S; de Pins A
  • Longitudinal study of inflammation and relapse in schizophrenia.
    Schizophr Res Volume: 252 Page(s): 88 - 95
    02/01/2023 Authors: Miller BJ; Lemos H; Schooler NR; Goff DC; Kopelowicz A; Lauriello J; Manschreck T; Mendelowitz A; Miller DD; Severe JB
  • A preliminary descriptive report of the longevity of the effects of Swedish Massage therapy for subjects with Generalized Anxiety Disorder.
    J Bodyw Mov Ther Volume: 33 Page(s): 176 - 181
    01/01/2023 Authors: Rapaport MH; Schettler PJ; Larson ER; Edwards SA; Dunlop BW; Rakofsky JJ; Kinkead B
  • The Relationship Between Major Depressive Disorder and Multiple Medical Conditions: A Call to Improve Integrated Care Services.
    J Clin Psychiatry Volume: 83
    10/19/2022 Authors: Weir RA; Rapaport MH
  • Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical Trial.
    J Clin Psychiatry Volume: 83
    08/22/2022 Authors: Mischoulon D; Dunlop BW; Kinkead B; Schettler PJ; Lamon-Fava S; Rakofsky JJ; Nierenberg AA; Clain AJ; Mletzko Crowe T; Wong A
  • Mapping genomic loci implicates genes and synaptic biology in schizophrenia.
    Nature Volume: 604 Page(s): 502 - 508
    04/01/2022 Authors: Trubetskoy V; Pardias AF; Qi T; Panagiotaropoulou G; Awasthi S; Bigdeli TB; Bryois J; Chen C-Y; Dennison CA; Hall LS
  • Rare coding variants in ten genes confer substantial risk for schizophrenia.
    Nature Volume: 604 Page(s): 509 - 516
    04/01/2022 Authors: Singh T; Poterba T; Curtis D; Akil H; Al Eissa M; Barchas JD; Bass N; Bigdeli TB; Breen G; Bromet EJ
  • A novel peripheral biomarker for depression and antidepressant response.
    Mol Psychiatry Volume: 27 Page(s): 1640 - 1646
    03/01/2022 Authors: Targum SD; Schappi J; Koutsouris A; Bhaumik R; Rapaport MH; Rasgon N; Rasenick MM
  • Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors.
    Biol Psychiatry Volume: 91 Page(s): 313 - 327
    02/01/2022 Authors: Mullins N; Kang J; Campos AI; Coleman JRI; Edwards AC; Galfalvy H; Levey DF; Lori A; Shabalin A; Starnawska A
  • Locus Coeruleus Noradrenergic Modulation of Diurnal Corticosterone, Stress Reactivity, and Cardiovascular Homeostasis in Male Rats.
    Neuroendocrinology Volume: 112 Page(s): 763 - 776
    01/01/2022 Authors: Thrivikraman KV; Kinkead B; Owens MJ; Rapaport MH; Plotsky PM
  • The United States index of socioeconomic deprivation for individuals (USiDep).
    Pers Med Psychiatry Volume: 31-32
    01/01/2022 Authors: Dunlop BW; Rakofsky JJ; Mischoulon D; Mayberg HS; Kinkead B; Nierenberg AA; Ziegler TR; Fava M; Rapaport MH
  • Longitudinal impact of bladder cancer diagnosis on common psychiatric disorders.
    Volume: 10 Page(s): 8412 - 8420
    12/01/2021 Authors: Cooke IJ; Patil D; Bobrek K; Narayan V; Master V; Rapaport M; Filson CP; Joshi SS
  • Transcutaneous Cervical Vagal Nerve Stimulation in Patients with Posttraumatic Stress Disorder (PTSD): A Pilot Study of Effects on PTSD Symptoms and Interleukin-6 Response to Stress.
    J Affect Disord Rep Volume: 6
    12/01/2021 Authors: Bremner JD; Wittbrodt MT; Gurel NZ; Shandhi MH; Gazi AH; Jiao Y; Levantsevych OM; Huang M; Beckwith J; Herring I
  • Characterisation of age and polarity at onset in bipolar disorder.
    Br J Psychiatry Volume: 219 Page(s): 659 - 669
    12/01/2021 Authors: Kalman JL; Olde Loohuis LM; Vreeker A; McQuillin A; Stahl EA; Ruderfer D; Grigoroiu-Serbanescu M; Panagiotaropoulou G; Ripke S; Bigdeli TB
  • Distinct gene-set burden patterns underlie common generalized and focal epilepsies.
    EBioMedicine Volume: 72 Page(s): 103588
    10/01/2021 Authors: Koko M; Krause R; Sander T; Bobbili DR; Nothnagel M; May P; Lerche H; Epi25 Collaborative
  • Psychiatry's modern role in functional neurological disorder: join the renaissance.
    Psychol Med Volume: 51 Page(s): 1961 - 1963
    09/01/2021 Authors: Bgue I; Nicholson TR; Kozlowska K; LaFrance WC; Levenson JL; Rapaport MH; Carson AJ; Perez DL
  • Prognostic value of polygenic risk scores for adults with psychosis.
    Nat Med Volume: 27 Page(s): 1576 - 1581
    09/01/2021 Authors: Landi I; Kaji DA; Cotter L; Van Vleck T; Belbin G; Preuss M; Loos RJF; Kenny E; Glicksberg BS; Beckmann ND
  • Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology.
    Nat Genet Volume: 53 Page(s): 817 - 829
    06/01/2021 Authors: Mullins N; Forstner AJ; O'Connell KS; Coombes B; Coleman JRI; Qiao Z; Als TD; Bigdeli TB; Brte S; Bryois J
  • Genome-Wide Association Studies of Schizophrenia and Bipolar Disorder in a Diverse Cohort of US Veterans.
    Schizophr Bull Volume: 47 Page(s): 517 - 529
    03/16/2021 Authors: Bigdeli TB; Fanous AH; Li Y; Rajeevan N; Sayward F; Genovese G; Gupta R; Radhakrishnan K; Malhotra AK; Sun N
  • Six versus twelve weeks of Swedish massage therapy for generalized anxiety disorder: Preliminary findings.
    Complement Ther Med Volume: 56 Page(s): 102593
    01/01/2021 Authors: Rapaport MH; Schettler PJ; Larson ER; Dunlop BW; Rakofsky JJ; Kinkead B
  • Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation.
    Prostaglandins Leukot Essent Fatty Acids Volume: 164 Page(s): 102219
    01/01/2021 Authors: Lamon-Fava S; So J; Mischoulon D; Ziegler TR; Dunlop BW; Kinkead B; Schettler PJ; Nierenberg AA; Felger JC; Maddipati KR
  • Treatment of functional neurological disorder: current state, future directions, and a research agenda.
    CNS Spectr Page(s): 1 - 7
    12/07/2020 Authors: LaFaver K; LaFrance WC; Price ME; Rosen PB; Rapaport M
  • Transcutaneous vagal nerve stimulation blocks stress-induced activation of Interleukin-6 and interferon- in posttraumatic stress disorder: A double-blind, randomized, sham-controlled trial.
    Brain Behav Immun Health Volume: 9 Page(s): 100138
    12/01/2020 Authors: Bremner JD; Gurel NZ; Jiao Y; Wittbrodt MT; Levantsevych OM; Huang M; Jung H; Shandhi MH; Beckwith J; Herring I
  • An agenda for functional neurological disorders: care and research.
    CNS Spectr Page(s): 1 - 2
    10/07/2020 Authors: Rommelfanger KS; Rapaport MH
  • Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry.
    Mol Psychiatry Volume: 25 Page(s): 2455 - 2467
    10/01/2020 Authors: Bigdeli TB; Genovese G; Georgakopoulos P; Meyers JL; Peterson RE; Iyegbe CO; Medeiros H; Valderrama J; Achtyes ED; Kotov R
  • Application of Noninvasive Vagal Nerve Stimulation to Stress-Related Psychiatric Disorders.
    J Pers Med Volume: 10
    09/09/2020 Authors: Bremner JD; Gurel NZ; Wittbrodt MT; Shandhi MH; Rapaport MH; Nye JA; Pearce BD; Vaccarino V; Shah AJ; Park J
  • Diet, Stress and Mental Health.
    Nutrients Volume: 12
    08/13/2020 Authors: Bremner JD; Moazzami K; Wittbrodt MT; Nye JA; Lima BB; Gillespie CF; Rapaport MH; Pearce BD; Shah AJ; Vaccarino V
  • Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits.
    Front Psychiatry Volume: 11 Page(s): 46
    01/01/2020 Authors: Goldsmith DR; Rapaport MH
  • Non-invasive vagal nerve stimulation decreases brain activity during trauma scripts.
    Brain Stimul Volume: 13 Page(s): 1333 - 1348
    01/01/2020 Authors: Wittbrodt MT; Gurel NZ; Nye JA; Ladd S; Shandhi MMH; Huang M; Shah AJ; Pearce BD; Alam ZS; Rapaport MH
  • Omega-3 fatty acids for major depressive disorder with high inflammation: A personalized approach
    Volume: 29 Page(s): S250 - S251
    12/01/2019 Authors: Mischoulon D; Dunlop B; Kinkead B; Schettler P; Lamon-Fava S; Nierenberg A; Felger J; Clain A; Mletzko T; Wong A
  • A Molecular Rationale for n-3 PUFA Augmentation of Antidepressant Action
    Volume: 44 Page(s): 434 - 434
    12/01/2019 Authors: Rapaport M; Mischoulon D; Dunlop B; Nierenberg A; Kinkead B; Lamon-Fava S; Schettler P; Ziegler T; Fava M
  • Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals.
    Am J Hum Genet Volume: 105 Page(s): 267 - 282
    08/01/2019 Authors: Epi25 Collaborative. Electronic address: s.berkovic@unimelb.edu.au; Epi25 Collaborative
  • Contribution of Rare Copy Number Variants toBipolar Disorder Risk Is Limited to Schizoaffective Cases.
    Biol Psychiatry Volume: 86 Page(s): 110 - 119
    07/15/2019 Authors: Charney AW; Stahl EA; Green EK; Chen C-Y; Moran JL; Chambert K; Belliveau RA; Forty L; Gordon-Smith K; Lee PH
  • Insomnia and suicidal ideation in nonaffective psychosis.
    Sleep Volume: 42
    02/01/2019 Authors: Miller BJ; Parker CB; Rapaport MH; Buckley PF; McCall WV
  • Current Role of Herbal and Natural Preparations.
    Handb Exp Pharmacol Volume: 250 Page(s): 225 - 252
    01/01/2019 Authors: Mischoulon D; Rapaport MH
  • The prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical program.
    PLoS One Volume: 14 Page(s): e0216937
    01/01/2019 Authors: Waserstein G; Partin C; Cohen D; Schettler P; Kinkead B; Rapaport MH
  • Prevalence and Impact of Psychiatric Symptoms in an Undiagnosed Diseases Program
    Volume: 43 Page(s): S347 - S347
    12/01/2018 Authors: Rapaport M; Partin C; Cohen D; Waserstein G; Kinkead B; Schettler P
  • Model structure for protocol adherence utilizing a manualized therapeutic massage intervention.
    J Complement Integr Med Volume: 16
    10/12/2018 Authors: Larson ER; Kinkead B; Edwards SA; Schettler PJ; Dunlop BW; Rakofsky JJ; Rapaport MH
  • Mood Disorders.
    Continuum (Minneap Minn) Volume: 24 Page(s): 804 - 827
    06/01/2018 Authors: Rakofsky J; Rapaport M
  • Massage therapy decreases cancer-related fatigue: Results from a randomized early phase trial.
    Cancer Volume: 124 Page(s): 546 - 554
    02/01/2018 Authors: Kinkead B; Schettler PJ; Larson ER; Carroll D; Sharenko M; Nettles J; Edwards SA; Miller AH; Torres MA; Dunlop BW
  • Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD).
    Brain Stimul Volume: 11 Page(s): 75 - 84
    01/01/2018 Authors: Fava M; Freeman MP; Flynn M; Hoeppner BB; Shelton R; Iosifescu DV; Murrough JW; Mischoulon D; Cusin C; Rapaport M
  • Massage Therapy for Psychiatric Disorders.
    Focus (Am Psychiatr Publ) Volume: 16 Page(s): 24 - 31
    01/01/2018 Authors: Rapaport MH; Schettler PJ; Larson ER; Carroll D; Sharenko M; Nettles J; Kinkead B
  • Vagus Nerve Stimulation: Back to the Future.
    Am J Psychiatry Volume: 174 Page(s): 609 - 610
    07/01/2017 Authors: Bremner JD; Rapaport MH
  • Transdiagnostic Clinical Global Impression Scoring for Routine Clinical Settings.
    Behav Sci (Basel) Volume: 7
    06/27/2017 Authors: Dunlop BW; Gray J; Rapaport MH
  • Beyond the Psychiatric Horizon: Preparing Residents for the Twenty-First Century.
    Acad Psychiatry Volume: 41 Page(s): 125 - 131
    02/01/2017 Authors: Rakofsky JJ; Cotes RO; McDonald WM; Schwartz AC; Rapaport MH
  • Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder.
    Transl Psychiatry Volume: 7 Page(s): e993
    01/10/2017 Authors: Charney AW; Ruderfer DM; Stahl EA; Moran JL; Chambert K; Belliveau RA; Forty L; Gordon-Smith K; Di Florio A; Lee PH
  • Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies.
    Psychother Psychosom Volume: 86 Page(s): 260 - 267
    01/01/2017 Authors: Griffiths CEM; Fava M; Miller AH; Russell J; Ball SG; Xu W; Acharya N; Rapaport MH
  • Disentangling Stigma from Functional Neurological Disorders: Conference Report and Roadmap for the Future.
    Front Neurol Volume: 8 Page(s): 106
    01/01/2017 Authors: Rommelfanger KS; Factor SA; LaRoche S; Rosen P; Young R; Rapaport MH
  • Swedish Massage Therapy Clinically and Statistically Reduced Fatigue in Breast Cancer Survivors
    Volume: 41 Page(s): S381 - S381
    12/01/2016 Authors: Rapaport M; Dunlop B; Kinkead B; Rakofsky J; Schettler P; Edwards S; Torres M; Larsen E; Allen L; Carroll D
  • A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.
    Mol Psychiatry Volume: 21 Page(s): 1696 - 1709
    12/01/2016 Authors: Goldsmith DR; Rapaport MH; Miller BJ
  • Psychiatry Departments Under Constrained Funding Mechanisms or What Is a Chairperson to Do?
    Acad Psychiatry Volume: 40 Page(s): 869 - 873
    12/01/2016 Authors: Magen J; Rapaport MH
  • Parental type 2 diabetes in patients with non-affective psychosis.
    Schizophr Res Volume: 175 Page(s): 223 - 225
    08/01/2016 Authors: Miller BJ; Goldsmith DR; Paletta N; Wong J; Kandhal P; Black C; Rapaport MH; Buckley PF
  • When Should a Patient Be Declared Recovered From a Major Depressive Episode?
    J Clin Psychiatry Volume: 77 Page(s): e1026 - e1028
    08/01/2016 Authors: Dunlop BW; Rapaport MH
  • Acute Swedish Massage Monotherapy Successfully Remediates Symptoms of Generalized Anxiety Disorder: A Proof-of-Concept, Randomized Controlled Study.
    J Clin Psychiatry Volume: 77 Page(s): e883 - e891
    07/01/2016 Authors: Rapaport MH; Schettler P; Larson ER; Edwards SA; Dunlop BW; Rakofsky JJ; Kinkead B
  • Short and long-term response and remission of depressive symptoms in psoriasis patients treated continuously with ixekizumab in UNCOVER-3
    Volume: 30 Page(s): 39 - 40
    07/01/2016 Authors: Griffiths CE; Fava M; Mrowietz U; Miller A; Russell J; Ball S; Zhang L; Acharya N; Rapaport M
  • Symptoms of psychosis in schizophrenia, schizoaffective disorder, and bipolar disorder: A comparison of African Americans and Caucasians in the Genomic Psychiatry Cohort.
    Am J Med Genet B Neuropsychiatr Genet Volume: 171 Page(s): 546 - 555
    06/01/2016 Authors: Perlman G; Kotov R; Fu J; Bromet EJ; Fochtmann LJ; Medeiros H; Genomic Psychiatry Cohort Consortium; Pato MT; Pato CN
  • Nicotine dependence and psychosis in Bipolar disorder and Schizoaffective disorder, Bipolar type.
    Am J Med Genet B Neuropsychiatr Genet Volume: 171 Page(s): 521 - 524
    06/01/2016 Authors: Estrada E; Hartz SM; Tran J; Hilty DM; Sklar P; Smoller JW; Genomic Psychiatry Cohort Consortium; Pato MT; Pato CN
  • Substance use associated with short sleep duration in patients with schizophrenia or schizoaffective disorder.
    Am J Med Genet B Neuropsychiatr Genet Volume: 171 Page(s): 525 - 533
    06/01/2016 Authors: Tang VK; Pato MT; Sobell JL; Hammond TC; Valdez MM; Lane CJ; Genomic Psychiatry Cohort Consortium; Pato CN
  • Paternal age effect: Replication in schizophrenia with intriguing dissociation between bipolar with and without psychosis.
    Am J Med Genet B Neuropsychiatr Genet Volume: 171 Page(s): 495 - 505
    06/01/2016 Authors: Lehrer DS; Pato MT; Nahhas RW; Miller BR; Malaspina D; Buckley PF; Sobell JL; Walsh-Messinger J; Genomic Psychiatry Cohort Consortium; Pato CN
  • Traumatic brain injury and bipolar psychosis in the Genomic Psychiatry Cohort.
    Am J Med Genet B Neuropsychiatr Genet Volume: 171 Page(s): 506 - 512
    06/01/2016 Authors: Cieslak K; Pato M; Buckley P; Pato C; Sobell JL; Medeiros H; Zhao Y; Ahn H; Genomic Psychiatry Cohort Consortium; Malaspina D
  • Impact of ixekizumab treatment on depressive symptoms: An integrated analysis of three phase 3 clinical studies in patients with moderate-to-severe psoriasis
    Volume: 74 Page(s): AB253 - AB253
    05/01/2016 Authors: Griffiths C; Fava M; Miller A; Russell J; Ball S; Xu I; Acharya N; Rapaport M
  • Inflammation in Psychotic and Mood Disorders: The Results From a Meta-analysis and Polygenic Risk Score Data from the Grady Trauma Project
    Volume: 79 Page(s): 285S - 286S
    05/01/2016 Authors: Rapaport MH
  • Lori L. Altshuler, MD 1957-2015.
    J Clin Psychiatry Volume: 77 Page(s): 333
    03/01/2016 Authors: Rapaport MH
  • Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study.
    Mol Psychiatry Volume: 21 Page(s): 71 - 79
    01/01/2016 Authors: Rapaport MH; Nierenberg AA; Schettler PJ; Kinkead B; Cardoos A; Walker R; Mischoulon D
  • Massage Therapy for GAD: Lessons Learned about Outcomes, Hormones, and Immune Function
    Volume: 40 Page(s): S47 - S47
    12/01/2015 Authors: Rapaport M
  • Patients' preference for complementary and alternative medicine presents challenges for research.
    J Clin Psychiatry Volume: 76 Page(s): e886 - e887
    07/01/2015 Authors: Rapaport MH
  • Antidepressant signal detection in the clinical trials vortex.
    J Clin Psychiatry Volume: 76 Page(s): e657 - e659
    05/01/2015 Authors: Dunlop BW; Rapaport MH
  • Clinical Predictors of Response to Omega-3 Fatty Acids in Major Depressive Disorder
    Volume: 77
    05/01/2015 Authors: Mischoulon D; Nierenberg AA; Schettler PJ; Kinkead B; Fehling K; Martinson M; Rapaport MH
  • META-ANALYSIS OF CYTOKINE ALTERATIONS IN ACUTELY ILL PSYCHIATRIC PATIENTS: COMPARISONS BETWEEN SCHIZOPHRENIA, BIPOLAR DISORDER, AND DEPRESSION
    Volume: 41 Page(s): S140 - S140
    03/01/2015 Authors: Goldsmith DR; Miller BJ; Rapaport MH
  • Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychoses.
    Brain Behav Immun Volume: 45 Page(s): 28 - 35
    03/01/2015 Authors: Miller BJ; Kandhal P; Rapaport MH; Mellor A; Buckley P
  • Psychiatric workforce needs and recommendations for the community mental health system: a state needs assessment.
    Psychiatr Serv Volume: 66 Page(s): 115 - 117
    02/01/2015 Authors: Walker ER; Berry FW; Citron T; Fitzgerald J; Rapaport MH; Stephens B; Druss BG
  • Polyunsaturated Fatty Acids in Adult Psychiatric Disorders: A Comprehensive Overview
    Page(s): 371 - 395
    01/01/2015 Authors: Saah T; Garlow SJ; Rapaport MH
  • A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression.
    J Clin Psychiatry Volume: 76 Page(s): 54 - 61
    01/01/2015 Authors: Mischoulon D; Nierenberg AA; Schettler PJ; Kinkead BL; Fehling K; Martinson MA; Hyman Rapaport M
  • A Study of Swedish Massage Therapy for Generalized Anxiety Disorder
    Volume: 39 Page(s): S339 - S339
    12/01/2014 Authors: Rapaport M; Schettler P; Kinkead B; Larsen E; Edwards S
  • Provide optimized antidepressant monotherapy with multiple drugs before considering antidepressant polypharmacy.
    Shanghai Arch Psychiatry Volume: 26 Page(s): 360 - 362
    12/01/2014 Authors: Saah T; Garlow SJ; Rapaport MH
  • Comorbidity of severe psychotic disorders with measures of substance use.
    JAMA Psychiatry Volume: 71 Page(s): 248 - 254
    03/01/2014 Authors: Hartz SM; Pato CN; Medeiros H; Cavazos-Rehg P; Sobell JL; Knowles JA; Bierut LJ; Pato MT; Genomic Psychiatry Cohort Consortium
  • C-reactive protein levels in schizophrenia: a review and meta-analysis.
    Clin Schizophr Relat Psychoses Volume: 7 Page(s): 223 - 230
    01/01/2014 Authors: Miller BJ; Culpepper N; Rapaport MH
  • Inflammation, Depression and N-3 Fatty Acids: A Case of Personalized Medicine
    NEUROPSYCHOPHARMACOLOGY Volume: 38 Page(s): S353 - S354
    12/01/2013 Authors: Rapaport MH; Schettler P; Pace TW; Kinkead B; Nierenberg AA; Mischoulon D
  • The prevalence and severity of depressive symptoms along the spectrum of unipolar depressive disorders: a post hoc analysis.
    J Clin Psychiatry Volume: 74 Page(s): 1084 - 1091
    11/01/2013 Authors: Rakofsky JJ; Schettler PJ; Kinkead BL; Frank E; Judd LL; Kupfer DJ; Rush AJ; Thase ME; Yonkers KA; Rapaport MH
  • Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder.
    J Psychiatr Res Volume: 47 Page(s): 1199 - 1203
    09/01/2013 Authors: Garlow SJ; Kinkead B; Thase ME; Judd LL; Rush AJ; Yonkers KA; Kupfer DJ; Frank E; Schettler PJ; Rapaport MH
  • Building an evidence base in complementary and integrative healthcare for child and adolescent psychiatry.
    Child Adolesc Psychiatr Clin N Am Volume: 22 Page(s): 509 - vii
    07/01/2013 Authors: Edwards E; Mischoulon D; Rapaport M; Stussman B; Weber W
  • The genomic psychiatry cohort: partners in discovery.
    Am J Med Genet B Neuropsychiatr Genet Volume: 162B Page(s): 306 - 312
    06/01/2013 Authors: Pato MT; Sobell JL; Medeiros H; Abbott C; Sklar BM; Buckley PF; Bromet EJ; Escamilla MA; Fanous AH; Lehrer DS
  • Prenatal inflammation and neurodevelopment in schizophrenia: a review of human studies.
    Prog Neuropsychopharmacol Biol Psychiatry Volume: 42 Page(s): 92 - 100
    04/05/2013 Authors: Miller BJ; Culpepper N; Rapaport MH; Buckley P
  • A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting.
    Qual Life Res Volume: 22 Page(s): 585 - 596
    04/01/2013 Authors: Ishak WW; Balayan K; Bresee C; Greenberg JM; Fakhry H; Christensen S; Rapaport MH
  • Teaching the teacher: a report from the third annual American Society of Clinical Psychopharmacology teaching session.
    J Clin Psychiatry Volume: 74 Page(s): 262 - 264
    03/01/2013 Authors: Glick ID; Zisook S; Rapaport MH
  • A simple question answered: adding moderate-dosage lithium does not help patients with bipolar disorder.
    Am J Psychiatry Volume: 170 Page(s): 9 - 11
    01/01/2013 Authors: Dunlop BW; Rakofsky JJ; Rapaport MH
  • A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder.
    J Clin Psychiatry Volume: 73 Page(s): 1541 - 1547
    12/01/2012 Authors: Papakostas GI; Vitolo OV; Ishak WW; Rapaport MH; Zajecka JM; Kinrys G; Mischoulon D; Lipkin SH; Hails KA; Abrams J
  • A preliminary study of the effects of repeated massage on hypothalamic-pituitary-adrenal and immune function in healthy individuals: a study of mechanisms of action and dosage.
    J Altern Complement Med Volume: 18 Page(s): 789 - 797
    08/01/2012 Authors: Rapaport MH; Schettler P; Bresee C
  • Memantine for Cognitive Dysfunction in Bipolar Disorder and Correlation with Hippocampal Neuronal Viability
    Volume: 71 Page(s): 59S - 60S
    04/15/2012 Authors: Iosifescu DV; Gilmer WS; Fan A; Gonenc A; Moore C; Randolph C; Rapaport MH; Peters A; Deckersbach T; Nierenberg AA
  • Application of external review for subject selection in a schizophrenia trial.
    J Clin Psychopharmacol Volume: 32 Page(s): 825 - 826
    04/01/2012 Authors: Targum SD; Little JA; Lopez E; Demartinis N; Rapaport M; Ereshefsky L
  • New Clinical Drug Evaluation Unit (NCDEU) annual meeting: a great opportunity for early career psychiatrists.
    J Clin Psychiatry Volume: 73 Page(s): 504 - 505
    04/01/2012 Authors: Kane JM; Hill LD; Kinon BJ; Potter WZ; Rapaport MH; Schooler NR
  • Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot study.
    Bipolar Disord Volume: 14 Page(s): 206 - 210
    03/01/2012 Authors: Fan A; Berg A; Bresee C; Glassman LH; Rapaport MH
  • Treating major depression by creating positive expectations for the future: a pilot study for the effectiveness of future-directed therapy (FDT) on symptom severity and quality of life.
    CNS Neurosci Ther Volume: 18 Page(s): 102 - 109
    02/01/2012 Authors: Vilhauer JS; Young S; Kealoha C; Borrmann J; IsHak WW; Rapaport MH; Hartoonian N; Mirocha J
  • Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder.
    J Clin Psychopharmacol Volume: 32 Page(s): 61 - 64
    02/01/2012 Authors: Gertsik L; Poland RE; Bresee C; Rapaport MH
  • Use of a relapse monitoring board: an independent assessment for determining relapse in clinical trials for bipolar disorder.
    Innov Clin Neurosci Volume: 8 Page(s): 19 - 24
    10/01/2011 Authors: Turner N; Macfadden W; Anand R; Khanna S; Rapaport MH; Haskins JT; Turkoz I; Alphs L
  • Attitude toward humor in patients experiencing depressive symptoms.
    Innov Clin Neurosci Volume: 8 Page(s): 20 - 23
    09/01/2011 Authors: Bokarius A; Ha K; Poland R; Bokarius V; Rapaport MH; Ishak WW
  • The treatment of minor depression with St. John's Wort or citalopram: failure to show benefit over placebo.
    J Psychiatr Res Volume: 45 Page(s): 931 - 941
    07/01/2011 Authors: Rapaport MH; Nierenberg AA; Howland R; Dording C; Schettler PJ; Mischoulon D
  • Omega-3 fatty acids and depression: from cellular mechanisms to clinical care.
    J Clin Psychiatry Volume: 72 Page(s): 258 - 259
    02/01/2011 Authors: Freeman MP; Rapaport MH
  • Quality of life: the ultimate outcome measure of interventions in major depressive disorder.
    Harv Rev Psychiatry Volume: 19 Page(s): 229 - 239
    01/01/2011 Authors: IsHak WW; Greenberg JM; Balayan K; Kapitanski N; Jeffrey J; Fathy H; Fakhry H; Rapaport MH
  • The impact of psychotherapy, pharmacotherapy, and their combination on quality of life in depression.
    Harv Rev Psychiatry Volume: 19 Page(s): 277 - 289
    01/01/2011 Authors: Ishak WW; Ha K; Kapitanski N; Bagot K; Fathy H; Swanson B; Vilhauer J; Balayan K; Bolotaulo NI; Rapaport MH
  • Researcher experiences with IRBs: a survey of members of the American College of Neuropsychopharmacology.
    IRB Volume: 33 Page(s): 14 - 20
    01/01/2011 Authors: Wisner KL; Conley RR; Taylor SF; Kosten T; Rapaport MH; Brown LS
  • Adapting to decreased industry support of CME: lifelong education in an "industry-lite" world.
    Acad Psychiatry Volume: 35 Page(s): 101 - 105
    01/01/2011 Authors: Yager J; Silverman JJ; Rapaport MH
  • A preliminary study of the effects of a single session of Swedish massage on hypothalamic-pituitary-adrenal and immune function in normal individuals.
    J Altern Complement Med Volume: 16 Page(s): 1079 - 1088
    10/01/2010 Authors: Rapaport MH; Schettler P; Breese C
  • Deficits in psychological well-being and quality-of-life in minor depression: implications for DSM-V.
    CNS Neurosci Ther Volume: 16 Page(s): 208 - 216
    08/01/2010 Authors: Nierenberg AA; Rapaport MH; Schettler PJ; Howland RH; Smith JA; Edwards D; Schneider T; Mischoulon D
  • Impact of systemic lupus erythematosus on health, family, and work: the patient perspective.
    Arthritis Care Res (Hoboken) Volume: 62 Page(s): 266 - 273
    02/01/2010 Authors: Robinson D; Aguilar D; Schoenwetter M; Dubois R; Russak S; Ramsey-Goldman R; Navarra S; Hsu B; Revicki D; Cella D
  • Serial mitogen-stimulated cytokine production from continuously ill patients with schizophrenia.
    Neuropsychopharmacology Volume: 35 Page(s): 428 - 434
    01/01/2010 Authors: Rapaport MH; Bresee C
  • The role of dopaminergic agents in improving quality of life in major depressive disorder.
    Curr Psychiatry Rep Volume: 11 Page(s): 503 - 508
    12/01/2009 Authors: IsHak WW; Davis M; Jeffrey J; Balayan K; Pechnick RN; Bagot K; Rapaport MH
  • Persistently increased serum soluble interleukin-2 receptors in continuously ill patients with schizophrenia.
    Int J Neuropsychopharmacol Volume: 12 Page(s): 861 - 865
    07/01/2009 Authors: Bresee C; Rapaport MH
  • Beyond acute treatment of depressive disorders.
    J Clin Psychiatry Volume: 70 Page(s): e21
    07/01/2009 Authors: Rapaport MH
  • Helping patients with depression achieve wellness.
    J Clin Psychiatry Volume: 70 Page(s): e11
    05/01/2009 Authors: Rapaport MH
  • The functional impact of subsyndromal depressive symptoms in bipolar disorder: data from STEP-BD.
    J Affect Disord Volume: 114 Page(s): 58 - 67
    04/01/2009 Authors: Marangell LB; Dennehy EB; Miyahara S; Wisniewski SR; Bauer MS; Rapaport MH; Allen MH
  • Future drugs for the treatment of depression: the need to look beyond monoamine systems.
    CNS Spectr Volume: 14 Page(s): 14 - 16
    03/01/2009 Authors: Rapaport MH
  • ECP news. The new investigator program at the NCDEU meeting: opportunities found for all.
    J Clin Psychiatry Volume: 70 Page(s): 130
    01/01/2009 Authors: Rapaport MH
  • Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial.
    J Clin Psychiatry Volume: 70 Page(s): 46 - 57
    01/01/2009 Authors: Rapaport MH; Lydiard RB; Pitts CD; Schaefer D; Bartolic EI; Iyengar M; Carfagno M; Lipschitz A
  • Qualifications for recertification: an important but evolving set of standards.
    J Clin Psychiatry Volume: 69 Page(s): 1829
    11/01/2008 Authors: Rapaport MH; Hales DJ
  • Future drugs for the treatment of unipolar depression
    Volume: 11 Page(s): 66 - 66
    07/01/2008 Authors: Rapaport MH
  • The role of oxytoncin, vasopressin and cortisol in the beneficial effects of massage therapy
    Volume: 63 Page(s): 1S - 1S
    04/01/2008 Authors: Rapaport MH; Hale KL; Koury M; Shubov A; Bresee CJ
  • Training psychiatric residents and fellows in a telepsychiatry clinic: a supervision model.
    Acad Psychiatry Volume: 32 Page(s): 393 - 399
    01/01/2008 Authors: Szeftel R; Hakak R; Meyer S; Naqvi S; Sulman-Smith H; Delrahim K; Rapaport M
  • Correlates of functioning in bipolar disorder.
    Psychopharmacol Bull Volume: 41 Page(s): 51 - 64
    01/01/2008 Authors: Gyulai L; Bauer MS; Marangell LB; Dennehy EB; Thase ME; Otto MW; Zhang H; Wisniewski SR; Miklowitz DJ; Rapaport MH
  • Clinical features and functioning of patients with minor depression.
    Psychother Psychosom Volume: 77 Page(s): 384 - 389
    01/01/2008 Authors: Howland RH; Schettler PJ; Rapaport MH; Mischoulon D; Schneider T; Fasiczka A; Delrahiem K; Maddux R; Lightfoot M; Nierenberg AA
  • The beneficial effects of massage therapy on psychiatric and biological measures
    Volume: 61 Page(s): 27S - 27S
    04/15/2007 Authors: Rapaport MH; Koury MA; Hale KL; Bresee CJ
  • Translating the evidence on atypical depression into clinical practice.
    J Clin Psychiatry Volume: 68 Page(s): e11
    04/01/2007 Authors: Rapaport MH; Thase ME
  • Contemporary approaches for an optimal treatment of major depression
    EUROPEAN PSYCHIATRY Volume: 22 Page(s): S72 - S72
    03/01/2007 Authors: Blier P; Trivedi MH; Rapaport MH
  • Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art.
    J Clin Psychiatry Volume: 68 Suppl 8 Page(s): 42 - 46
    01/01/2007 Authors: Rapaport MH
  • Translating the evidence on atypical depression into clinical practice.
    J Clin Psychiatry Volume: 68 Suppl 3 Page(s): 31 - 36
    01/01/2007 Authors: Hyman Rapaport M
  • Efficacy and safety of bifeprunox versus placebo in the treatment of patients with acute exacerbations of schizophrenia
    Volume: 31 Page(s): S184 - S184
    12/01/2006 Authors: Rapaport M; Barbato LM; Heisterberg J; Yeung PP; Shapira NA
  • Time to response in generalized anxiety disorder in a naturalistic setting: combination therapy with alprazolam orally disintegrating tablets and serotonin reuptake inhibitors compared to serotonin reuptake inhibitors alone.
    Psychiatry (Edgmont) Volume: 3 Page(s): 50 - 59
    12/01/2006 Authors: Rapaport MH; Skarky SB; Katzelnick DJ; Dewester JN; Harper JM; McCrary KE
  • Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation.
    Neuropsychopharmacology Volume: 31 Page(s): 2505 - 2513
    11/01/2006 Authors: Rapaport MH; Gharabawi GM; Canuso CM; Mahmoud RA; Keller MB; Bossie CA; Turkoz I; Lasser RA; Loescher A; Bouhours P
  • A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder.
    J Clin Psychiatry Volume: 67 Page(s): 1674 - 1681
    11/01/2006 Authors: Shelton RC; Haman KL; Rapaport MH; Kiev A; Smith WT; Hirschfeld RMA; Lydiard RB; Zajecka JM; Dunner DL
  • Conflict of interest, round 2.
    Am J Psychiatry Volume: 163 Page(s): 1481 - 1483
    09/01/2006 Authors: Freedman R; Lewis DA; Michels R; Pine DS; Schultz SK; Tamminga C; Patterson SL; McIntyre JS; Goldman HH; Yudofsky SC
  • Clinicians on the front line: active management of depression and anxiety in primary care.
    JAAPA Volume: Suppl Page(s): 4 - 21
    07/01/2006 Authors: Culpepper L; Judd CR; Moller MD; Nemeroff CB; Rapaport MH; Ciraulo DA
  • The effects of celecoxib augmentation on cytokine levels in schizophrenia.
    Int J Neuropsychopharmacol Volume: 9 Page(s): 343 - 348
    06/01/2006 Authors: Bresee CJ; Delrahim K; Maddux RE; Dolnak D; Ahmadpour O; Rapaport MH
  • Cytokine alterations in medication-stabilized patients with schizophrenia
    Volume: 59 Page(s): 55S - 55S
    04/15/2006 Authors: Rapaport MH; Bresee CJ
  • Classification and treatment of sub-threshold depression.
    Curr Opin Psychiatry Volume: 19 Page(s): 9 - 13
    01/01/2006 Authors: Rowe SK; Rapaport MH
  • Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.
    Biol Psychiatry Volume: 58 Page(s): 347 - 354
    09/01/2005 Authors: Rush AJ; Marangell LB; Sackeim HA; George MS; Brannan SK; Davis SM; Howland R; Kling MA; Rittberg BR; Burke WJ
  • Celecoxib augmentation of continuously ill patients with schizophrenia.
    Biol Psychiatry Volume: 57 Page(s): 1594 - 1596
    06/15/2005 Authors: Rapaport MH; Delrahim KK; Bresee CJ; Maddux RE; Ahmadpour O; Dolnak D
  • Quality-of-life impairment in depressive and anxiety disorders.
    Am J Psychiatry Volume: 162 Page(s): 1171 - 1178
    06/01/2005 Authors: Rapaport MH; Clary C; Fayyad R; Endicott J
  • Determinants of functioning in bipolar disorders - a study of patients in the Systematic Treatment Enhancement Program for Bipolar Disorders (STEP-BD)
    Volume: 7 Page(s): 63 - 63
    06/01/2005 Authors: Gyulai L; Bauer MS; Marangell LB; Wisniewski SR; Dennehy E; Otto MW; Zhang H; Miklowitz D; Kogan J; Baldassano CF
  • Magnitude of placebo response and drug-placebo differences across psychiatric disorders.
    Psychol Med Volume: 35 Page(s): 743 - 749
    05/01/2005 Authors: Khan A; Kolts RL; Rapaport MH; Krishnan KRR; Brodhead AE; Browns WA
  • COX-2 inhibitor augmentation therapy for schizophrenia
    Volume: 57 Page(s): 131S - 131S
    04/15/2005 Authors: Rapaport MH; Bresee CJ; Delrahim K; Maddux R; Dolnick D; Ahmadpour O
  • Fluoxetine not found to increase suicidality over placebo during treatment of adults with minor depressive disorder
    Volume: 57 Page(s): 191S - 191S
    04/15/2005 Authors: Thase ME; Rush AJ; Rapaport MH; Yonkers KA; Kupfer DJ; Judd LL; Plewes JM; Schettler PJ
  • Risperidone augmentation of treatment-resistant depression: Brain metabolite alterations associated with treatment response
    Volume: 57 Page(s): 163S - 163S
    04/15/2005 Authors: Gertsik L; Moser F; Rapaport MH; Canuso CM; Gharabawi G; Walling DP; Renshaw PF; Chun ZS; Poland RE
  • TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament.
    J Affect Disord Volume: 85 Page(s): 45 - 52
    03/01/2005 Authors: Akiskal HS; Mendlowicz MV; Jean-Louis G; Rapaport MH; Kelsoe JR; Gillin JC; Smith TL
  • Temperament in the clinical differentiation of depressed bipolar and unipolar major depressive patients.
    J Affect Disord Volume: 84 Page(s): 219 - 223
    02/01/2005 Authors: Mendlowicz MV; Akiskal HS; Kelsoe JR; Rapaport MH; Jean-Louis G; Gillin JC
  • Affective state and EEG sleep profile in response to rapid tryptophan depletion in recently recovered nonmedicated depressed individuals.
    J Affect Disord Volume: 83 Page(s): 253 - 262
    12/01/2004 Authors: Haynes PL; McQuaid JR; Kelsoe J; Rapaport M; Gillin JC
  • Augmentation with risperidone in chronic resistant depression: A double-blind placebo-controlled maintenance trial
    Volume: 29 Page(s): S159 - S159
    12/01/2004 Authors: Nemeroff CB; Gharabawi GM; Canuso CM; Mahmoud R; Loescher A; Turkoz I; Rapaport MH; Gharabawi GM
  • Emerging treatment options in treatment-resistant depression and anxiety disorders
    Volume: 9 Page(s): 25 - 32
    12/01/2004 Authors: IsHak WW; Rapaport MH; Gotto JG
  • Treatment resistance: Concepts and management in mood and anxiety disorders
    CNS SPECTRUMS Volume: 9 Page(s): 5 - 5
    12/01/2004 Authors: Rapaport MH
  • The effectiveness of atypical antipsychotic medications in depressive disorders.
    Curr Psychiatry Rep Volume: 6 Page(s): 422 - 424
    12/01/2004 Authors: Ishak WW; Rapaport MH; Gotto JG
  • Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores.
    Schizophr Res Volume: 71 Page(s): 155 - 165
    11/01/2004 Authors: Lenert LA; Sturley AP; Rapaport MH; Chavez S; Mohr PE; Rupnow M
  • Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder.
    Am J Psychiatry Volume: 161 Page(s): 1864 - 1871
    10/01/2004 Authors: Judd LL; Rapaport MH; Yonkers KA; Rush AJ; Frank E; Thase ME; Kupfer DJ; Plewes JM; Schettler PJ; Tollefson G
  • The effects of typical and atypical antipsychotics on the cytokine network in schizophrenia
    Volume: 7 Page(s): S73 - S73
    06/01/2004 Authors: Rapaport MH; Bresee CJ
  • Results from the open-label phase of ARISe-RD (augmentation with risperidone in resistant depression)
    Volume: 7 Page(s): S345 - S345
    06/01/2004 Authors: Canuso C; Gharabawi G; Bouhours P; Leblanc J; Dunbar F; Rapaport MH
  • Escitalopram improves somatic symptoms of depression
    Volume: 7 Page(s): S348 - S348
    06/01/2004 Authors: Rapaport MH; Bose A; Saikali KG
  • Improvement in quality-of-life with risperidone augmentation in treatment-resistant depression
    VALUE IN HEALTH Volume: 7 Page(s): 279 - 279
    05/01/2004 Authors: Walling D; Rupnow M; Canuso C; Gharabawi G; Turkoz I; Rapaport M
  • Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD.
    Bipolar Disord Volume: 6 Page(s): 139 - 143
    04/01/2004 Authors: Marangell LB; Martinez JM; Ketter TA; Bowden CL; Goldberg JF; Calabrese JR; Miyahara S; Miklowitz DJ; Sachs GS; Thase ME
  • Paroxetine controlled release - A viewpoint by Mark H. Rapaport
    CNS DRUGS Volume: 18 Page(s): 366 - 366
    01/01/2004 Authors: Rapaport MH
  • Escitalopram continuation treatment prevents relapse of depressive episodes.
    J Clin Psychiatry Volume: 65 Page(s): 44 - 49
    01/01/2004 Authors: Rapaport MH; Bose A; Zheng H
  • Quality of life in geriatric patients with mood and anxiety disorders.
    CNS Spectr Volume: 8 Page(s): 35 - 47
    12/01/2003 Authors: Maddux RE; Delrahim KK; Rapaport MH
  • A quantitative neuromotor predictor of antidepressant non-response in patients with major depression.
    J Affect Disord Volume: 77 Page(s): 135 - 141
    11/01/2003 Authors: Caligiuri MP; Gentili V; Eberson S; Kelsoe J; Rapaport M; Gillin JC
  • Effects of lamotrigine on quality of life in patients with bipolar I disorder
    Volume: 13 Page(s): S457 - S458
    09/01/2003 Authors: Rapaport M; Kennedy S; Davis K
  • Efficacy of controlled-release paroxetine in the treatment of late-life depression.
    J Clin Psychiatry Volume: 64 Page(s): 1065 - 1074
    09/01/2003 Authors: Rapaport MH; Schneider LS; Dunner DL; Davies JT; Pitts CD
  • Use of the quality of well-being self-administered version (QWB-SA) in assessing health-related quality of life in depressed patients.
    J Affect Disord Volume: 76 Page(s): 237 - 247
    09/01/2003 Authors: Pyne JM; Sieber WJ; David K; Kaplan RM; Hyman Rapaport M; Keith Williams D
  • Studies characterizing 60 kda autoantibodies in subjects with schizophrenia.
    Biol Psychiatry Volume: 53 Page(s): 361 - 375
    03/01/2003 Authors: Wang X-F; Wang D; Zhu W; Delrahim KK; Dolnak D; Rapaport MH
  • Rapid tryptophan depletion reverses phenelzine-induced suppression of REM sleep.
    J Sleep Res Volume: 12 Page(s): 13 - 18
    03/01/2003 Authors: Landolt H-P; Kelsoe JR; Rapaport MH; Gillin JC
  • Challenges in the development of clinical trials for major depressive disorder: lessons learned from trials in minor depression.
    Dialogues Clin Neurosci Volume: 4 Page(s): 402 - 407
    12/01/2002 Authors: Rapaport MH; Maddux RE
  • Effects of rapid tryptophan depletion on sleep electroencephalogram and mood in subjects with partially remitted depression on bupropion.
    Neuropsychopharmacology Volume: 27 Page(s): 1016 - 1026
    12/01/2002 Authors: Evans L; Golshan S; Kelsoe J; Rapaport M; Resovsky K; Sutton L; Gillin JC
  • Quality of life in anxiety and depressive disorders
    EUROPEAN NEUROPSYCHOPHARMACOLOGY Volume: 12 Page(s): S356 - S356
    10/01/2002 Authors: Rapaport M; Endicott J; Fayyad R; Clary C
  • Reboxetine augmentation of fluoxetine for patients with major depressive disorder: An 8-week open-label study
    EUROPEAN NEUROPSYCHOPHARMACOLOGY Volume: 12 Page(s): S205 - S205
    10/01/2002 Authors: Rapaport M; Wilcox C; Heiser J; Londborg P; Schwartz G
  • Escitalopram prevents relapse of depressive episodes
    EUROPEAN PSYCHIATRY Volume: 17 Page(s): 97S - 97S
    05/01/2002 Authors: Rapaport MH; Bose A; Zheng H
  • Sleep EEG topography in patients suffering from moderate depression
    SLEEP Volume: 25 Page(s): A13 - A14
    04/15/2002 Authors: Landolt H; Achermann P; Kelsoe JR; Rapaport MH; Gillin JC
  • A descriptive analysis of minor depression.
    Am J Psychiatry Volume: 159 Page(s): 637 - 643
    04/01/2002 Authors: Rapaport MH; Judd LL; Schettler PJ; Yonkers KA; Thase ME; Kupfer DJ; Frank E; Plewes JM; Tollefson GD; Rush AJ
  • Amnesia and neonaticide.
    Am J Psychiatry Volume: 159 Page(s): 498 - 499
    03/01/2002 Authors: Mendlowicz MV; Rapaport MH; Fontenelle L; Jean-Louis G; De Moraes TM
  • Long-term antidepressant treatment.
    Psychopharmacol Bull Volume: 36 Page(s): 26 - 38
    01/01/2002 Authors: Delrahim KK; Maddux R; Rapaport MH
  • Long-term antidepressant treatment.
    Psychopharmacol Bull Volume: 36 Page(s): 26 - 38
    01/01/2002 Authors: Delrahim KK; Maddux R; Rapaport MH
  • Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.
    J Psychiatr Res Volume: 36 Page(s): 229 - 236
    01/01/2002 Authors: Pollack MH; Rapaport MH; Fayyad R; Otto MW; Nierenberg AA; Clary CM
  • Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment.
    J Clin Psychiatry Volume: 63 Page(s): 59 - 65
    01/01/2002 Authors: Rapaport MH; Endicott J; Clary CM
  • Rapid tryptophan depletion plus a serotonin 1A agonist: competing effects on sleep in healthy men.
    Neuropsychopharmacology Volume: 25 Page(s): S40 - S44
    11/01/2001 Authors: Moore P; Seifritz E; Schlosser A; Greenfield D; Stahl S; Rapaport M; Kelsoe J
  • Sertraline treatment of panic disorder: results of a long-term study.
    Acta Psychiatr Scand Volume: 104 Page(s): 289 - 298
    10/01/2001 Authors: Rapaport MH; Wolkow R; Rubin A; Hackett E; Pollack M; Ota KY
  • Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration.
    Ophthalmology Volume: 108 Page(s): 1893 - 1900
    10/01/2001 Authors: Brody BL; Gamst AC; Williams RA; Smith AR; Lau PW; Dolnak D; Rapaport MH; Kaplan RM; Brown SI
  • Does rapid tryptophan depletion induce depressive relapse? Response
    NEUROPSYCHOPHARMACOLOGY Volume: 25 Page(s): 615 - 615
    10/01/2001 Authors: Moore P; Gillin JC; Rapaport M; Kelsoe J
  • An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder.
    J Clin Psychiatry Volume: 62 Page(s): 789 - 796
    10/01/2001 Authors: Gillin JC; Smith-Vaniz A; Schnierow B; Rapaport MH; Kelsoe J; Raimo E; Marler MR; Goyette LM; Stein MB; Zisook S
  • The effects of lithium on ex vivo cytokine production.
    Biol Psychiatry Volume: 50 Page(s): 217 - 224
    08/01/2001 Authors: Rapaport MH; Manji HK
  • Panic disorder.
    Curr Psychiatry Rep Volume: 3 Page(s): 295 - 301
    08/01/2001 Authors: Rapaport MH; Barrett C
  • An abbreviated review of immune abnormalities in schizophrenia.
    CNS Spectr Volume: 6 Page(s): 392 - 397
    05/01/2001 Authors: Rapaport MH; Delrahim KK
  • Relationship of mood disturbance to cigarette smoking status among 252 patients with a current mood disorder.
    J Clin Psychiatry Volume: 62 Page(s): 319 - 324
    05/01/2001 Authors: Patten CA; Gillin JC; Golshan S; Wolter TD; Rapaport M; Kelsoe J
  • The effects of rapid tryptophan depletion on mood and sleep in euthymic depressed patients and normal controls
    BIOLOGICAL PSYCHIATRY Volume: 49 Page(s): 147S - 147S
    04/15/2001 Authors: Gillin JC; Moore P; Landolt H; Evans L; Kelsoe J; Rapaport M
  • A pilot study investigating the acute effects of olanzapine and risperidone on motor function
    SCHIZOPHRENIA RESEARCH Volume: 49 Page(s): 242 - 242
    04/15/2001 Authors: Rapaport MH; Dolnak DR; Caligiuri M
  • Motor predictors of antidepressant response
    BIOLOGICAL PSYCHIATRY Volume: 49 Page(s): 38S - 38S
    04/15/2001 Authors: Caligiuri M; Gentili V; Rapaport M; Kelsoe J; Gillin C
  • The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression.
    Neuropsychopharmacology Volume: 24 Page(s): 350 - 358
    04/01/2001 Authors: Thorsteinsson HS; Gillin JC; Patten CA; Golshan S; Sutton LD; Drummond S; Clark CP; Kelsoe J; Rapaport M
  • Absence of neuropsychologic deficits in patients receiving long-term treatment with alprazolam-XR for panic disorder.
    J Clin Psychopharmacol Volume: 21 Page(s): 131 - 138
    04/01/2001 Authors: Gladsjo JA; Rapaport MH; McKinney R; Auerbach M; Hahn T; Rabin A; Oliver T; Haze A; Judd LL
  • Sleep and sleep electroencephalogram in depressed patients treated with phenelzine.
    Arch Gen Psychiatry Volume: 58 Page(s): 268 - 276
    03/01/2001 Authors: Landolt HP; Raimo EB; Schnierow BJ; Kelsoe JR; Rapaport MH; Gillin JC
  • The mood-lowering effect of tryptophan depletion: Possible explanation for discrepant findings - Reply
    ARCHIVES OF GENERAL PSYCHIATRY Volume: 58 Page(s): 201 - 202
    02/01/2001 Authors: Moore PJ; Gillin JC; Landolt HP; Rapaport M; Kelsoe J
  • The mood-lowering effect of tryptophan depletion: possible explanation for discrepant findings.
    Arch Gen Psychiatry Volume: 58 Page(s): 200 - 202
    02/01/2001 Authors: Van der Does AJ
  • Panic disorder and response to sertraline: the effect of previous treatment with benzodiazepines.
    J Clin Psychopharmacol Volume: 21 Page(s): 104 - 107
    02/01/2001 Authors: Rapaport MH; Pollack MH; Clary CM; Mardekian J; Wolkow R
  • A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22.
    Proc Natl Acad Sci U S A Volume: 98 Page(s): 585 - 590
    01/16/2001 Authors: Kelsoe JR; Spence MA; Loetscher E; Foguet M; Sadovnick AD; Remick RA; Flodman P; Khristich J; Mroczkowski-Parker Z; Brown JL
  • Trait contributions of complex dysregulated behavioral organization in schizophrenic patients.
    Biol Psychiatry Volume: 49 Page(s): 71 - 77
    01/01/2001 Authors: Paulus MP; Rapaport MH; Braff DL
  • Prevalence, recognition, and treatment of comorbid depression and anxiety.
    J Clin Psychiatry Volume: 62 Suppl 24 Page(s): 6 - 10
    01/01/2001 Authors: Rapaport MH
  • Sertraline treatment of panic disorder: response in patients at risk for poor outcome.
    J Clin Psychiatry Volume: 61 Page(s): 922 - 927
    12/01/2000 Authors: Pollack MH; Rapaport MH; Clary CM; Mardekian J; Wolkow R
  • Clinical and physiological consequences of rapid tryptophan depletion.
    Neuropsychopharmacology Volume: 23 Page(s): 601 - 622
    12/01/2000 Authors: Moore P; Landolt HP; Seifritz E; Clark C; Bhatti T; Kelsoe J; Rapaport M; Gillin JC
  • Evaluating the parent-of-origin effect in bipolar affective disorder. Is a more penetrant subtype transmitted paternally?
    J Affect Disord Volume: 59 Page(s): 183 - 192
    09/01/2000 Authors: Kornberg JR; Brown JL; Sadovnick AD; Remick RA; Keck PE; McElroy SL; Rapaport MH; Thompson PM; Kaul JB; Vrabel CM
  • Sleep estimation from wrist activity in patients with major depression.
    Physiol Behav Volume: 70 Page(s): 49 - 53
    07/01/2000 Authors: Jean-Louis G; Mendlowicz MV; Gillin JC; Rapaport MH; Kelsoe JR; Zizi F; Landolt H; von Gizycki H
  • Preliminary evidence of an association between increased REM density and poor antidepressant response to partial sleep deprivation.
    J Affect Disord Volume: 59 Page(s): 77 - 83
    07/01/2000 Authors: Clark C; Dupont R; Golshan S; Gillin JC; Rapaport MH; Kelsoe JR
  • Is placebo response the same as drug response in panic disorder?
    Am J Psychiatry Volume: 157 Page(s): 1014 - 1016
    06/01/2000 Authors: Rapaport MH; Pollack M; Wolkow R; Mardekian J; Clary C
  • The role of serotonin in the pathophysiology and treatment of depression and its sleep disturbances
    INTERNATIONAL JOURNAL OF PSYCHOLOGY Volume: 35 Page(s): 209 - 209
    06/01/2000 Authors: Gillin JC; Kelsoe J; Landolt H; Moore P; Raimo E; Rapaport M; Schnierow B; Seifritz E
  • Use of objective measures of motor function to differentiate olanzapine and risperidone
    BIOLOGICAL PSYCHIATRY Volume: 47 Page(s): 39S - 39S
    04/15/2000 Authors: Rapaport MH; Dolnak D; Caligiuri MP
  • The identification of a putative 60 kDa autoantibody in schizophrenia
    BIOLOGICAL PSYCHIATRY Volume: 47 Page(s): 38S - 39S
    04/15/2000 Authors: Rapaport MH; Wang DR; Wang XF; Zhu WG; Chavez S; Dolnak D; Cole D
  • The interaction between the immune system and psychiatric disorders
    BIOLOGICAL PSYCHIATRY Volume: 47 Page(s): 4S - 4S
    04/15/2000 Authors: Rapaport MH; Wong C; Yehuda R; Lavia M
  • Sociodemographic predictors of temperament and character.
    J Psychiatr Res Volume: 34 Page(s): 221 - 226
    01/01/2000 Authors: Mendlowicz MV; Jean-Louis G; Gillin JC; Akiskal HS; Furlanetto LM; Rapaport MH; Kelsoe JR
  • Mothers murdering their newborns in the hospital.
    Gen Hosp Psychiatry Volume: 22 Page(s): 53 - 55
    01/01/2000 Authors: Mendlowicz MV; da Silva Filho JF; Gekker M; de Moraes TM; Rapaport MH; Jean-Louis F
  • Quality of well being in panic disorder: the assessment of psychiatric and general disability.
    J Affect Disord Volume: 57 Page(s): 217 - 221
    01/01/2000 Authors: Rubin HC; Rapaport MH; Levine B; Gladsjo JK; Rabin A; Auerbach M; Judd LL; Kaplan R
  • A genome survey indicates a susceptibility locus for bipolar disorder on chromosome 22: Further support from two additional family sets.
    MOLECULAR PSYCHIATRY Volume: 4 Page(s): S74 - S74
    09/01/1999 Authors: Kelsoe JR; Spence MA; Loetscher E; Sadovnick AD; Remick RA; Keck PE; McElroy S; Mroczkowski-Parker Z; Shekhtman T; Brown JL
  • Analysis of GNAZ gene polymorphism in bipolar affective disorder.
    Am J Med Genet Volume: 88 Page(s): 324 - 328
    08/20/1999 Authors: Saito T; Papolos DF; Chernak D; Rapaport MH; Kelsoe JR; Lachman HM
  • Neonaticide in the city of Rio de Janeiro: forensic and psycholegal perspectives.
    J Forensic Sci Volume: 44 Page(s): 741 - 745
    07/01/1999 Authors: Mendlowicz MV; Jean-Louis G; Gekker M; Rapaport MH
  • Motor slowing in schizophrenia patients with deficit syndrome
    BIOLOGICAL PSYCHIATRY Volume: 45 Page(s): 25S - 25S
    04/15/1999 Authors: Caligiuri MP; Rapaport MH
  • Evidence of chronic immune activation in schizophrenia
    SCHIZOPHRENIA RESEARCH Volume: 36 Page(s): 107 - 108
    04/01/1999 Authors: Rapaport MH; Wang XP
  • A preliminary analysis investigating immune activation in schizophrenia
    Page(s): 101 - 114
    01/01/1999 Authors: Rapaport MH; Caliguiri MP; Lohr JB; Dolnak D; Chavez S; Kulesh C; Hahn T
  • Immune parameters in rapid cycling bipolar patients before and after lithium treatment.
    J Psychiatr Res Volume: 33 Page(s): 335 - 340
    01/01/1999 Authors: Rapaport MH; Guylai L; Whybrow P
  • A comparison of descriptive characteristics of male outpatients and inpatients with affective disorders.
    Int Clin Psychopharmacol Volume: 13 Page(s): 245 - 252
    11/01/1998 Authors: Mendlowicz MV; Rapaport MH; Thompson P; Kelsoe JR; Golshan S; Judd LL; Gillin JC
  • Sleep electroencephalographic response to muscarinic and serotonin1A receptor probes in patients with major depression and in normal controls.
    Biol Psychiatry Volume: 44 Page(s): 21 - 33
    07/01/1998 Authors: Seifritz E; Gillin JC; Rapaport MH; Kelsoe JR; Bhatti T; Stahl SM
  • Rapid tryptophan depletion, sleep electroencephalogram, and mood in men with remitted depression on serotonin reuptake inhibitors.
    Volume: 55 Page(s): 534 - 539
    06/01/1998 Authors: Moore P; Gillin C; Bhatti T; DeModena A; Seifritz E; Clark C; Stahl S; Rapaport M; Kelsoe J
  • A neuropsychological study of panic disorder: negative findings.
    J Affect Disord Volume: 49 Page(s): 123 - 131
    05/01/1998 Authors: Gladsjo JA; Rapaport MH; McKinney R; Lucas JA; Rabin A; Oliver T; Davis J; Auerbach M; Judd LL
  • Immune system activation and motor dysfunction in schizophrenia
    BIOLOGICAL PSYCHIATRY Volume: 43 Page(s): 67S - 67S
    04/15/1998 Authors: Rapaport M; Caligiuri M
  • Circulating lymphocyte phenotypic surface markers in anxiety disorder patients and normal volunteers.
    Biol Psychiatry Volume: 43 Page(s): 458 - 463
    03/15/1998 Authors: Rapaport MH
  • Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment.
    J Affect Disord Volume: 48 Page(s): 227 - 232
    03/01/1998 Authors: Rapaport MH; Judd LL
  • Residential treatment for patients in crisis.
    Psychiatr Serv Volume: 49 Page(s): 246
    02/01/1998 Authors: Dolnak D; Rapaport MH; Hawthorne W
  • A case-control study on the socio-demographic characteristics of 53 neonaticidal mothers.
    Int J Law Psychiatry Volume: 21 Page(s): 209 - 219
    01/01/1998 Authors: Mendlowicz MV; Rapaport MH; Mecler K; Golshan S; Moraes TM
  • The efficacy of new pharmacological treatments for panic disorder: evaluating the trials.
    Psychopharmacol Bull Volume: 34 Page(s): 167 - 168
    01/01/1998 Authors: Rapaport MH; Davidson JR
  • Methodologies and outcomes from the sertraline multicenter flexible-dose trials.
    Psychopharmacol Bull Volume: 34 Page(s): 183 - 189
    01/01/1998 Authors: Rapaport MH; Wolkow RM; Clary CM
  • Effects of a tryptophan-free amino acid drink challenge on normal human sleep electroencephalogram and mood.
    Volume: 43 Page(s): 52 - 59
    01/01/1998 Authors: Bhatti T; Gillin JC; Seifritz E; Moore P; Clark C; Golshan S; Stahl S; Rapaport M; Kelsoe J
  • Evidence for possible genetic linkage of the dopamine transporter locus to bipolar disorder.
    AMERICAN JOURNAL OF MEDICAL GENETICS Volume: 74 Page(s): 664 - 665
    11/21/1997 Authors: Kelsoe JR; Loetscher E; Spence MA; Foguet M; Sadovnick AD; Remick RA; Flodman P; Charara N; Kalkuloglu F; Homer J
  • Clinical differences between the generic and nongeneric forms of clonazepam.
    J Clin Psychopharmacol Volume: 17 Page(s): 424
    10/01/1997 Authors: Rapaport MH
  • Symptomatic volunteers different from patients with depressive disorders? Reply
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY Volume: 17 Page(s): 324 - 324
    08/01/1997 Authors: Rapaport MH
  • Moclobemide in social phobia: a controlled dose-response trial.
    J Clin Psychopharmacol Volume: 17 Page(s): 247 - 254
    08/01/1997 Authors: Noyes R; Moroz G; Davidson JR; Liebowitz MR; Davidson A; Siegel J; Bell J; Cain JW; Curlik SM; Kent TA
  • An association between increased serum-soluble interleukin-2 receptors and a disturbance in muscle force in schizophrenic patients.
    Prog Neuropsychopharmacol Biol Psychiatry Volume: 21 Page(s): 817 - 827
    07/01/1997 Authors: Rapaport MH; Caligiuri MP; Lohr JB
  • CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteers.
    Schizophr Res Volume: 25 Page(s): 123 - 129
    05/24/1997 Authors: Rapaport MH; McAllister CG; Pickar D; Tamarkin L; Kirch DG; Paul SM
  • A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
    J Clin Psychiatry Volume: 58 Page(s): 185 - 192
    05/01/1997 Authors: Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
  • Linkage studies suggest a possible locus for bipolar disorder near the velo-cardio-facial syndrome region on chromosome 22.
    Am J Med Genet Volume: 74 Page(s): 121 - 128
    04/18/1997 Authors: Lachman HM; Kelsoe JR; Remick RA; Sadovnick AD; Rapaport MH; Lin M; Pazur BA; Roe AM; Saito T; Papolos DF
  • Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association.
    Am J Psychiatry Volume: 154 Page(s): 1 - 63
    04/01/1997
  • The role of subsyndromal depressive symptoms in unipolar major depression
    Page(s): 6 - 10
    01/01/1997 Authors: Judd LL; Paulus M; Akiskal HS; Rapaport MH; Kunovac JL
  • Panic disorder in a managed care environment.
    J Clin Psychiatry Volume: 58 Suppl 2 Page(s): 51 - 55
    01/01/1997 Authors: Rapaport MH; Cantor JJ
  • An open-label study of SSRI treatment in depressed hispanic and non-Hispanic women.
    J Clin Psychiatry Volume: 58 Page(s): 31
    01/01/1997 Authors: Alonso M; Val E; Rapaport MH
  • Possible locus for bipolar disorder near the dopamine transporter on chromosome 5.
    Am J Med Genet Volume: 67 Page(s): 533 - 540
    11/22/1996 Authors: Kelsoe JR; Sadovnick AD; Kristbjarnarson H; Bergesch P; Mroczkowski-Parker Z; Drennan M; Rapaport MH; Flodman P; Spence MA; Remick RA
  • Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population.
    Am J Psychiatry Volume: 153 Page(s): 1411 - 1417
    11/01/1996 Authors: Judd LL; Paulus MP; Wells KB; Rapaport MH
  • A comparison of fluvoxamine and fluoxetine in the treatment of major depression.
    J Clin Psychopharmacol Volume: 16 Page(s): 373 - 378
    10/01/1996 Authors: Rapaport M; Coccaro E; Sheline Y; Perse T; Holland P; Fabre L; Bradford D
  • Ipsapirone, a 5-HT1A agonist, suppresses REM sleep equally in unmedicated depressed patients and normal controls.
    Neuropsychopharmacology Volume: 15 Page(s): 109 - 115
    08/01/1996 Authors: Gillin JC; Sohn JW; Stahl SM; Lardon M; Kelsoe J; Rapaport M; Ruiz C; Golshan S
  • A comparison of descriptive variables for clinical patients and symptomatic volunteers with depressive disorders.
    J Clin Psychopharmacol Volume: 16 Page(s): 242 - 246
    06/01/1996 Authors: Rapaport MH; Zisook S; Frevert T; Seymour S; Kelsoe JR; Judd LL
  • Genetic linkage study of bipolar disorder and the serotonin transporter.
    Am J Med Genet Volume: 67 Page(s): 215 - 217
    04/09/1996 Authors: Kelsoe JR; Remick RA; Sadovnick AD; Kristbjarnarson H; Flodman P; Spence MA; Morison M; Mroczkowski-Parker Z; Bergesch P; Rapaport MH
  • Comparison of descriptive variables for symptomatic volunteers and clinical patients with anxiety disorders.
    Anxiety Volume: 2 Page(s): 117 - 122
    01/01/1996 Authors: Rapaport MH; Frevert T; Babior S; Seymour S; Zisook S; Kelsoe J; Judd LL
  • No antidepressant effect of biperiden compared with placebo in depression: a double-blind 6-week clinical trial.
    Psychiatry Res Volume: 58 Page(s): 99 - 105
    09/29/1995 Authors: Gillin JC; Lauriello J; Kelsoe JR; Rapaport M; Golshan S; Kenny WM; Sutton L
  • Gender differences in outpatient research subjects with affective disorders: a comparison of descriptive variables.
    J Clin Psychiatry Volume: 56 Page(s): 67 - 72
    02/01/1995 Authors: Rapaport MH; Thompson PM; Kelsoe JR; Golshan S; Judd LL; Gillin JC
  • A review of social phobia.
    Psychopharmacol Bull Volume: 31 Page(s): 125 - 129
    01/01/1995 Authors: Rapaport MH; Paniccia G; Judd LL
  • A comparison of demographic variables, symptom profiles, and measurements of functioning in symptomatic volunteers and an outpatient clinical population.
    Psychopharmacol Bull Volume: 31 Page(s): 111 - 114
    01/01/1995 Authors: Rapaport MH; Frevert T; Babior S; Zisook S; Judd LL
  • Retraumatization of Holocaust survivors during the Gulf War and SCUD missile attacks on Israel.
    Br J Med Psychol Volume: 67 Page(s): 353 - 362
    12/01/1994 Authors: Robinson S; Hemmendinger J; Netanel R; Rapaport M; Zilberman L; Gal A
  • Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia.
    Acta Psychiatr Scand Volume: 90 Page(s): 311 - 315
    11/01/1994 Authors: Rapaport MH; Lohr JB
  • Immune parameters in euthymic bipolar patients and normal volunteers.
    J Affect Disord Volume: 32 Page(s): 149 - 156
    11/01/1994 Authors: Rapaport MH
  • National Depression Screening Day: the San Diego experience.
    Hosp Community Psychiatry Volume: 45 Page(s): 1042 - 1043
    10/01/1994 Authors: Rapaport MH; Suminski M
  • The effects of prolonged lithium exposure on the immune system of normal control subjects: serial serum soluble interleukin-2 receptor and antithyroid antibody measurements.
    Biol Psychiatry Volume: 35 Page(s): 761 - 766
    05/15/1994 Authors: Rapaport MH; Schmidt ME; Risinger R; Manji H
  • Increased serum soluble interleukin-2 receptors in Caucasian and Korean schizophrenic patients.
    Biol Psychiatry Volume: 35 Page(s): 767 - 771
    05/15/1994 Authors: Rapaport MH; McAllister CG; Kim YS; Han JH; Pickar D; Nelson DL; Kirch DG; Paul SM
  • Missed psychiatric appointments.
    Am J Psychiatry Volume: 151 Page(s): 786
    05/01/1994 Authors: Rapaport MH
  • Subsyndromal symptomatic depression: a new mood disorder?
    J Clin Psychiatry Volume: 55 Suppl Page(s): 18 - 28
    04/01/1994 Authors: Judd LL; Rapaport MH; Paulus MP; Brown JL
  • Carbon-dioxide-induced panic.
    Am J Psychiatry Volume: 151 Page(s): 292
    02/01/1994 Authors: Rapaport MH
  • Serum interleukin-2 and soluble interleukin-2 receptor levels in generalized social phobia.
    Anxiety Volume: 1 Page(s): 50 - 53
    01/01/1994 Authors: Rapaport MH; Stein MB
  • Serum cytokine and soluble interleukin-2 receptors in patients with panic disorder.
    Anxiety Volume: 1 Page(s): 22 - 25
    01/01/1994 Authors: Rapaport MH; Stein MB
  • Beneficial effects of nalmefene augmentation in neuroleptic-stabilized schizophrenic patients.
    Neuropsychopharmacology Volume: 9 Page(s): 111 - 115
    09/01/1993 Authors: Rapaport MH; Wolkowitz O; Kelsoe JR; Pato C; Konicki PE; Pickar D
  • [Late effects of massive psychic trauma. Holocaust survivors 50 years later].
    Minerva Psichiatr Volume: 34 Page(s): 57 - 63
    03/01/1993 Authors: Robinson S; Rebaudengo-Rosca P; Rapaport M
  • A comparison of ICD-10 and DSM-III-R criteria for substance abuse and dependence.
    Am J Drug Alcohol Abuse Volume: 19 Page(s): 143 - 151
    01/01/1993 Authors: Rapaport MH; Tipp JE; Schuckit MA
  • Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins.
    Eur Arch Psychiatry Clin Neurosci Volume: 243 Page(s): 7 - 10
    01/01/1993 Authors: Rapaport MH; Torrey EF; McAllister CG; Nelson DL; Pickar D; Paul SM
  • The cholinergic REM sleep induction test with pilocarpine in mildly depressed patients and normal controls.
    Biol Psychiatry Volume: 33 Page(s): 33 - 39
    01/01/1993 Authors: Lauriello J; Kenny WM; Sutton L; Golshan S; Ruiz C; Kelsoe J; Rapaport M; Gillin JC
  • Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine.
    Arch Gen Psychiatry Volume: 49 Page(s): 345 - 353
    05/01/1992 Authors: Pickar D; Owen RR; Litman RE; Konicki E; Gutierrez R; Rapaport MH
  • Haloperidol and soluble interleukin-2 receptors.
    Biol Psychiatry Volume: 30 Page(s): 1063 - 1064
    11/15/1991 Authors: Rapaport MH; Doran AR; Nelson DL; McAllister C; Magliozzi JR; Paul SM
  • INCREASED PERCENTAGES OF LYMPHOCYTES-T IN THE CSF OF SCHIZOPHRENIC-PATIENTS
    SCHIZOPHRENIA RESEARCH Volume: 4 Page(s): 373 - 373
    05/01/1991 Authors: MCALLISTER CG; KONICKI E; KIRCH DG; RAPAPORT MH; PAUL SM; PICKAR D
  • The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness.
    Biol Psychiatry Volume: 29 Page(s): 715 - 717
    04/01/1991 Authors: Rapaport MH; McAllister CG; Kirch DG; Pickar D
  • The effects of physostigmine infusion on patients with panic disorder.
    Biol Psychiatry Volume: 29 Page(s): 658 - 664
    04/01/1991 Authors: Rapaport MH; Risch SC; Gillin JC; Golshan S; Janowsky D
  • NIMH bulletins and redundant publication.
    Biol Psychiatry Volume: 29 Page(s): 307 - 308
    02/01/1991 Authors: Regier DA; Shore D; Rapaport MH; Prien R; Keith SJ
  • The late effects of Nazi persecution among elderly Holocaust survivors.
    Acta Psychiatr Scand Volume: 82 Page(s): 311 - 315
    10/01/1990 Authors: Robinson S; Rapaport J; Durst R; Rapaport M; Rosca P; Metzer S; Zilberman L
  • Effects of the acute administration of caffeine in patients with schizophrenia.
    Biol Psychiatry Volume: 28 Page(s): 35 - 40
    07/01/1990 Authors: Lucas PB; Pickar D; Kelsoe J; Rapaport M; Pato C; Hommer D
  • Increased numbers of CD5+ B lymphocytes in schizophrenic patients.
    Arch Gen Psychiatry Volume: 46 Page(s): 890 - 894
    10/01/1989 Authors: McAllister CG; Rapaport MH; Pickar D; Podruchny TA; Christison G; Alphs LD; Paul SM
  • Effects of short-term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients.
    Arch Gen Psychiatry Volume: 46 Page(s): 956 - 957
    10/01/1989 Authors: McAllister CG; Rapaport MH; Pickar D; Paul SM
  • Neuroendocrine effects of ovine corticotropin-releasing hormone in panic disorder patients.
    Biol Psychiatry Volume: 26 Page(s): 344 - 348
    08/01/1989 Authors: Rapaport MH; Risch SC; Golshan S; Gillin JC
  • Long-lasting behavioral changes following prednisone withdrawal.
    JAMA Volume: 261 Page(s): 1731 - 1732
    03/24/1989 Authors: Wolkowitz OM
  • Elevated levels of soluble interleukin 2 receptors in schizophrenia.
    Arch Gen Psychiatry Volume: 46 Page(s): 291 - 292
    03/01/1989 Authors: Rapaport MH; McAllister CG; Pickar D; Nelson DL; Paul SM
  • Blunted growth hormone response to peripheral infusion of human growth hormone-releasing factor in patients with panic disorder.
    Am J Psychiatry Volume: 146 Page(s): 92 - 95
    01/01/1989 Authors: Rapaport MH; Risch SC; Gillin JC; Golshan S; Janowsky DS
  • Smooth pursuit eye movements in schizophrenia: effects of neuroleptic treatment and caffeine.
    Psychopharmacol Bull Volume: 25 Page(s): 473 - 478
    01/01/1989 Authors: Litman RE; Hommer DW; Clem T; Rapaport MH; Pato CN; Pickar D
  • Benzodiazepine augmentation of neuroleptic treatment in patients with schizophrenia.
    Psychopharmacol Bull Volume: 25 Page(s): 263 - 266
    01/01/1989 Authors: Pato CN; Wolkowitz OM; Rapaport M; Schulz SC; Pickar D
  • Neuroendocrine effects of intravenous ovine corticotropin-releasing factor in affective disorder patients and normal controls.
    Biol Psychiatry Volume: 23 Page(s): 755 - 758
    04/01/1988 Authors: Risch SC; Golshan S; Rapaport MH; Dupont R; Outenreath R; Gillin JC; Janowsky DS
  • Factors influencing outpatient attrition.
    Psychiatr Med Volume: 6 Page(s): 41 - 54
    01/01/1988 Authors: Rapaport MH; Zisook S; Lyons LE
  • Metabolic stress effects in normal volunteers and schizophrenic patients.
    Psychopharmacol Bull Volume: 24 Page(s): 431 - 433
    01/01/1988 Authors: Breier A; Wolkowitz OM; Rapaport M; Paul SM; Pickar D
  • Research diagnostic problems.
    Am J Psychiatry Volume: 144 Page(s): 826 - 827
    06/01/1987 Authors: Rapaport MH; Cummings MA; Cummings KL; Risch SC
  • Acquired immunodeficiency syndrome presenting as schizophrenia.
    West J Med Volume: 146 Page(s): 615 - 618
    05/01/1987 Authors: Cummings MA; Cummings KL; Rapaport MH; Atkinson JH; Grant I
  • Requests by walk-in and scheduled patients at an outpatient clinic. Walk-in needs more varied and greater in number.
    Psychosomatics Volume: 28 Page(s): 129 - 142
    03/01/1987 Authors: Rapaport MH; Zisook S
  • REQUESTS BY WALK-IN AND SCHEDULED PATIENTS AT AN OUTPATIENT-CLINIC
    PSYCHOSOMATICS Volume: 28 Page(s): 129 - &
    03/01/1987 Authors: RAPAPORT MH; ZISOOK S
  • Chronic pain and posttraumatic stress disorder.
    Am J Psychiatry Volume: 144 Page(s): 120
    01/01/1987 Authors: Rapaport MH
  • A psychiatric staff response to acquired immune deficiency syndrome.
    Am J Psychiatry Volume: 143 Page(s): 682
    05/01/1986 Authors: Cummings MA; Rapaport M; Cummings KL
  • AIDS and homosexual panic.
    Am J Psychiatry Volume: 142 Page(s): 1516
    12/01/1985 Authors: Rapaport M; Braff DL
  • Transderm scopolamine efficacy related to time of application prior to the onset of motion.
    Aviat Space Environ Med Volume: 56 Page(s): 591 - 593
    06/01/1985 Authors: Levy GD; Rapaport MH
  • Alprazolam and hostility.
    Am J Psychiatry Volume: 142 Page(s): 146
    01/01/1985 Authors: Rapaport M; Braff DL
  • Validation of the Scale of Functioning in Older Outpatients With Schizophrenia.
    Am J Geriatr Psychiatry Volume: 4 Page(s): 218 - 228
    Authors: Rapaport MH; Bazzetta J; McAdams LA; Patterson T; Jeste DV
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2024 Emory University
  • Privacy Policy
  • Emergency Information